Suchergebnisse - "Verweij, Paul E"

PubPharm (25)

1

Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Jansen, A. | Muilwijk, E. | van der Velden, W. | +8

2

Exposure to intravenous posaconazole in critically ill patients with influenza : A pharmacokinetic analysis of the POSA-FLU study

enthalten in: Mycoses | 2022

von Van Daele, R. | Wauters, J. | Dreesen, E. | +9

3

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU) : a randomised, open-label, proof-of-concept trial

enthalten in: Intensive care medicine | 2021

von Vanderbeke, L. | Janssen, N. | Bergmans, D. | +37

CommentIn: Intensive Care Med. 2021 Nov;47(11):1341-1342. - PMID 34374834

4

Pharmacokinetics and Pharmacodynamics of Posaconazole

enthalten in: Drugs | 2020

von Chen, L. | Krekels, E. | Verweij, P. | +3

5

Implications for IV posaconazole dosing in the era of obesity

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Wasmann, R. | Smit, C. | van Donselaar, M. | +6

6

High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infections

enthalten in: Mycoses | 2020

von Schauwvlieghe, A. | Buil, J. | Verweij, P. | +6

7

In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Oliveira Dos Santos, C. | Kolwijck, E. | van der Lee, H. | +6

8

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Buil, J. | Brüggemann, R. | Wasmann, R. | +5

ErratumIn: J Antimicrob Chemother. 2018 Jan 1;73(1):263. - PMID 29112717

9

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017

von Heo, S. | Tatara, A. | Jiménez-Ortigosa, C. | +10

10

Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method

enthalten in: Antimicrobial agents and chemotherapy | 2017

von Mello, E. | Posteraro, B. | Vella, A. | +5